henhao
Sign in
BioinformaticsScience China Life Sciences
Peer-reviewed journal article

Hi-TOM: a platform for high-throughput tracking of mutations induced by CRISPR/Cas systems

Qing LiuiD, Chun WangiD, Xiaozhen Jiao, Huawei ZhangiD, Lili SongiD, Yanxin LiiD, Caixia GaoiD, Kejian WangiD

PDFDOIPreprint

Abstract

The CRISPR/Cas system has been extensively applied to make precise genetic modifications in various organisms. Despite its importance and widespread use, large-scale mutation screening remains time-consuming, labour-intensive and costly. Here, we describe a cheap, practicable and high-throughput screening strategy that allows parallel screening of 96 x N (N denotes the number of targets) genome-modified sites. The strategy simplified and streamlined the process of next-generation sequencing (NGS) library construction by fixing the bridge sequences and barcoding primers. We also developed Hi-TOM (available at http://www.hi-tom.net/hi-tom/), an online tool to track the mutations with precise percentage. Analysis of the samples from rice, hexaploid wheat and human cells reveals that the Hi-TOM tool has high reliability and sensitivity in tracking various mutations, especially complex chimeric mutations that frequently induced by genome editing. Hi-TOM does not require specially design of barcode primers, cumbersome parameter configuration or additional data analysis. Thus, the streamlined NGS library construction and comprehensive result output make Hi-TOM particularly suitable for high-throughput identification of all types of mutations induced by CRISPR/Cas systems.

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISSymeonidi '20Huang '23Nandy '18Brinkman '18Hodgens '17Zhang '19
62% semantic matchPlant Biology
E. Symeonidi, J. Regalado, R. Schwab+1 more·bioRxiv·Jun 25, 2020